PAVmed Inc.PAVMEarnings & Financial Report
Nasdaq
PAVM Q3 2025 Key Financial Metrics
Revenue
$5.0K
Gross Profit
$-50.0K
Operating Profit
$-4.8M
Net Profit
$-5.4M
Gross Margin
-1000.0%
Operating Margin
-96880.0%
Net Margin
-107660.0%
YoY Growth
-99.5%
EPS
$-0.29
Financial Flow
PAVmed Inc. Q3 2025 Financial Summary
PAVmed Inc. reported revenue of $5.0K for Q3 2025, with a net profit of $-5.4M (-107660.0% margin). Cost of goods sold was $55.0K, operating expenses totaled $4.8M.
Key Financial Metrics
| Total Revenue | $5.0K |
|---|---|
| Net Profit | $-5.4M |
| Gross Margin | -1000.0% |
| Operating Margin | -96880.0% |
| Report Period | Q3 2025 |
PAVmed Inc. Annual Revenue by Year
PAVmed Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $3.0M).
| Year | Annual Revenue |
|---|---|
| 2024 | $3.0M |
| 2023 | $2.5M |
| 2022 | $377.0K |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.0M | $1.0M | $979000 | $996000 | $10000 | $8000 | $6000 | $5000 |
| YoY Growth | 836.6% | 126.5% | 489.8% | 25.9% | -99.0% | -99.2% | -99.4% | -99.5% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $33.1M | $37.3M | $39.4M | $30.6M | $30.7M | $52.8M | $43.9M | $38.1M |
| Liabilities | $57.1M | $57.8M | $58.1M | $39.9M | $37.7M | $11.9M | $12.5M | $12.3M |
| Equity | $-53.8M | $-68.8M | $-73.9M | $-4.9M | $-2.5M | $45.0M | $37.5M | $32.5M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-11.9M | $-13.1M | $-11.7M | $-8.9M | $94000 | $-1.6M | $-1.2M | $-896000 |